Charles Russell Speechlys has an experienced Private Equity team that boasts an indepth knowledge of advising on all aspects of private equity transactions including MBOs, MBIs, buy-and-builds, secondary buy-outs and exits.
We act for private equity houses, management teams and investee companies and have the capability to act on all stages of the life cycle from fund formation, to investment, to ultimate exit. Members of the team have experience of working on the full range of private equity transactions from small cap to some of the largest deals.
We also act for venture and growth capital investors, be they business angels, high net worth investors, venture capital or venture debt funders or providers of growth capital. We also advise early stage and high growth companies seeking investment including SEIS, EIS and VCT qualifying investments, rounds of venture capital funding and growth capital investment. We act for entrepreneurs as they seek to establish and develop their businesses.
A unique aspect of our offering is our strong private client presence, which gives us access to family offices, high and ultra-high net worth individuals as well as business owners. This presents opportunities from a private equity perspective, including in relation to assisting deal origination and ability to refer transactions.
We also have a full service offering in all areas necessary to support transactional work including strong Banking & Finance and Corporate Tax teams with experience of advising on all aspects of debt financing and tax related matters relevant to private equity transactions. In addition, we have teams in the full suite of specialist areas including intellectual property, competition, employment, pensions, real estate, commercial dispute resolution and restructuring.
This year the team have been shortlisted for:
- Law Firm of the Year – Deal Structuring award at the unquote British Private Equity Awards;
- Private Equity Team of the Year at the British Legal Awards;
- Regional/ Specialist Legal Adviser of the Year Advisory Award at the Real Deals Private Equity Awards; and
- Service Provider of the Year at the Investor Allstars Awards
News & Insights
Charles Russell Speechlys double shortlisted for 2017 British Legal Awards
We are delighted to be shortlisted for Private Equity and Private Client team of the year.
Charles Russell Speechlys advises Kreos Capital on its €15 million growth capital investment
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer.
Charles Russell Speechlys advises Kreos Capital and Silicon Valley Bank on growth capital investment to Mereo BioPharma
Mereo BioPharma is a UK-based specialty bio-pharmaceutical company listed on the AIM market of the London Stock Exchange.
Charles Russell Speechlys shortlisted for 'Service Provider of the Year' in the Investor Allstars Awards
We are delighted to be recognised for our Venture and Growth Capital work.